Biogen’s outrageous original price for Aduhelm, $56,000 per year, is the poster child for how dysfunctional our drug pricing system has become and it is the perfect example of why Medicare should be negotiating drug prices with the pharmaceutical industry. If the administration takes no action, Medicare recipients will continue to see their biggest premium More

The post On Medicare Limiting Coverage for Alzheimer’s Drug appeared first on CounterPunch.org.

This post was originally published on CounterPunch.org.